. . . . . . . . . "pulmozyme r in cf patients with an fvc 4 of predicted daily administration of pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics pulmozyme is a recombinant dnase enzyme indicated in conjunction with standard therapies for the management of cystic fibrosis cf patients to improve pulmonary function 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "apKQ2rdv9oREBCIc38cNFSQq39Toq5OAudEPVCF+uGJpRLVhiAZfxGfNuf4PLPGiaSy/YI/MUHZeALMqVgvgtL8zuYTxrZhANmSidCv8MkXlrKiHuzoLnyYwvbQypOuQUqXJFdZOeRO5LKL5qdUmwlnaMZbew1Wu0daUK8U0aSk=" . . "2021-06-12T12:30:51.524+02:00"^^ . . . . .